CYP26A1
Reactivité: Humain, Souris, Rat
WB, ELISA, ICC, IF
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Western Blot (1-2 μg/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1-5 μg/mL) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In PBS (0.08 % sodium azide)
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Store at -20°C. Aliquot to avoid repeated freezing and thawing.
Osanai, Petkovich: "Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death." dans: Molecular pharmacology, Vol. 67, Issue 5, pp. 1808-17, (2005) (PubMed).
Kumarakulasingham, Rooney, Dundas, Telfer, Melvin, Curran, Murray: "Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 11, Issue 10, pp. 3758-65, (2005) (PubMed).
Sakai, Luo, McCaffery, Hamada, Dräger: "CYP26A1 and CYP26C1 cooperate in degrading retinoic acid within the equatorial retina during later eye development." dans: Developmental biology, Vol. 276, Issue 1, pp. 143-57, (2004) (PubMed).
Antigène
CYP26A1
(Cytochrome P450, Family 26, Subfamily A, Polypeptide 1 (CYP26A1))